Rahmi Aslan, et al. “RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy”. Turkish Journal of Gastroenterology, vol. 34, no. 3, Mar. 2023, pp. 310-, https://tjg.avesjournals.com/index.php/tjg/article/view/4414.